1. Home
  2. STKE vs CCEL Comparison

STKE vs CCEL Comparison

Compare STKE & CCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

STKE

Sol Strategies Inc.

N/A

Current Price

$1.31

Market Cap

37.3M

Sector

N/A

ML Signal

N/A

Logo Cryo-Cell International Inc.

CCEL

Cryo-Cell International Inc.

HOLD

Current Price

$3.30

Market Cap

32.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
STKE
CCEL
Founded
2002
1989
Country
Canada
United States
Employees
N/A
N/A
Industry
Managed Health Care
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
37.3M
32.7M
IPO Year
N/A
2022

Fundamental Metrics

Financial Performance
Metric
STKE
CCEL
Price
$1.31
$3.30
Analyst Decision
Hold
Analyst Count
0
1
Target Price
N/A
N/A
AVG Volume (30 Days)
157.7K
12.6K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
4.41%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$25,384,279.00
Revenue This Year
$15.56
$0.30
Revenue Next Year
$44.24
N/A
P/E Ratio
N/A
$20.00
Revenue Growth
N/A
9.76
52 Week Low
$1.18
$3.10
52 Week High
$7.75
$7.70

Technical Indicators

Market Signals
Indicator
STKE
CCEL
Relative Strength Index (RSI) 41.75 42.04
Support Level $1.18 $3.33
Resistance Level $2.80 $3.57
Average True Range (ATR) 0.13 0.11
MACD 0.03 0.01
Stochastic Oscillator 40.00 35.82

Price Performance

Historical Comparison
STKE
CCEL

About STKE Sol Strategies Inc.

Sol Strategies Inc is engaged in investing in blockchain technologies and crypto currencies. Company executes its Investment Objective through three lines of effort: Treasury management: Maintaining a core portfolio of cryptocurrencies for long-term growth, enhanced with risk management strategies to minimize volatility, and generating yield through lending, staking, and liquidity provisioning; Private equity focused on early stage companies in the DeFi and blockchain sectors; and Active investments to generate yield through strategic activities, including Bitcoin mining and stalking and validating Solana.

About CCEL Cryo-Cell International Inc.

Cryo-Cell International Inc is engaged in cellular processing and cryogenic storage. The company is organized into three reportable segments namely cellular processing and cryogenic storage, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells for family use and the manufacturing of PrepaCyte CB units segment, which is a processing technology used to process umbilical cord blood stem cells. The Public cord blood banking segment consists of cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The company generates maximum revenue from Cellular processing and Cryogenic storage and it derives revenue from processing and testing fees and Storage segment.

Share on Social Networks: